calcium channel, voltage-dependent, beta 2 subunit |
TERFENADINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.624uM |
.607uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
TERFENADINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.624uM |
.607uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
TERFENADINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.624uM |
.607uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
TERFENADINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.624uM |
.607uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
TERFENADINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.624uM |
.607uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
TERFENADINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.624uM |
.607uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
TERFENADINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.624uM |
.607uM |
View
|
adrenergic receptor, alpha 1b |
PROMAZINE |
Adrenergic alpha1B |
100% |
.008187uM |
.004532uM |
View
|
adrenergic receptor, alpha 1d (Non-specific probe) |
DIHYDROERGOCRISTINE MESYLATE |
Adrenergic alpha1D |
100% |
.007369uM |
.003622uM |
View
|
adrenergic receptor, alpha 2b |
DIHYDROERGOCRISTINE MESYLATE |
Adrenergic alpha2B |
100% |
.0079uM |
.003606uM |
View
|
5-hydroxytryptamine receptor 6 |
DIHYDROERGOCRISTINE MESYLATE |
Serotonin 5-HT6 |
100% |
.042uM |
.019uM |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
AZASETRON |
Serotonin 5-HT3 |
100% |
.013uM |
.00289uM |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
AZASETRON |
Serotonin 5-HT3 |
100% |
.013uM |
.00289uM |
View
|
histamine receptor H 1 |
PYRILAMINE |
Histamine H1, Central |
100% |
.003721uM |
.000432uM |
View
|
adrenergic receptor, alpha 2b |
QUETIAPINE |
Adrenergic alpha2B |
100% |
.1003uM |
.0458uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
QUETIAPINE |
Serotonin 5-HT2B |
100% |
.2135uM |
.1359uM |
View
|
5-hydroxytryptamine (serotonin) receptor 1B |
DIHYDROERGOCRISTINE MESYLATE |
Serotonin 5-HT1B |
100% |
.024uM |
.011uM |
View
|
adrenergic receptor, alpha 1a |
ERGOTAMINE |
Adrenergic alpha1A |
100% |
.00806uM |
.003262uM |
View
|
adrenergic receptor, alpha 1b |
DIHYDROERGOCRISTINE MESYLATE |
Adrenergic alpha1B |
100% |
.002298uM |
.001272uM |
View
|
histamine receptor H 1 |
QUETIAPINE |
Histamine H1, Central |
100% |
.0396uM |
.004599uM |
View
|
dopamine receptor D3 |
ERGOTAMINE |
Dopamine D3 |
100% |
.004311uM |
.001464uM |
View
|
adrenergic receptor, alpha 1b |
ERGOTAMINE |
Adrenergic alpha1B |
100% |
.008214uM |
.004547uM |
View
|
adrenergic receptor, alpha 2a |
ERGOTAMINE |
Adrenergic alpha2A |
100% |
.002123uM |
.000796uM |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
PROMAZINE |
Adrenergic, Norepinephrine Transporter |
100% |
.013uM |
.013uM |
View
|
dopamine receptor D3 |
PROMAZINE |
Dopamine D3 |
100% |
.205uM |
.069uM |
View
|
dopamine receptor D3 |
DIHYDROERGOCRISTINE MESYLATE |
Dopamine D3 |
100% |
.002288uM |
.000777uM |
View
|
adrenergic receptor, beta 2 |
(S)-(-)-PINDOLOL |
Adrenergic beta2 |
100% |
.001571uM |
.00108uM |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
(S)-(-)-PINDOLOL |
Serotonin 5-HT1A |
100% |
.028uM |
.016uM |
View
|
adrenergic receptor, alpha 2b |
ERGOTAMINE |
Adrenergic alpha2B |
100% |
.003844uM |
.001755uM |
View
|
5-hydroxytryptamine (serotonin) receptor 5B |
ERGOTAMINE |
Serotonin 5-HT4 |
100% |
1.584uM |
.264uM |
View
|
5-hydroxytryptamine (serotonin) receptor 4 |
ERGOTAMINE |
Serotonin 5-HT4 |
100% |
1.584uM |
.264uM |
View
|
5-hydroxytryptamine receptor 6 |
ERGOTAMINE |
Serotonin 5-HT6 |
100% |
.002042uM |
.000948uM |
View
|
adrenergic receptor, alpha 1d (Non-specific probe) |
LISURIDE |
Adrenergic alpha1D |
100% |
.041uM |
.02uM |
View
|
adrenergic receptor, alpha 2b |
LISURIDE |
Adrenergic alpha2B |
100% |
.000518uM |
.000237uM |
View
|
adrenergic receptor, alpha 1a |
THIORIDAZINE |
Adrenergic alpha1A |
100% |
.005093uM |
.002062uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
LISURIDE |
Serotonin 5-HT2A |
100% |
.00304uM |
.000868uM |
View
|
adrenergic receptor, alpha 1a |
LISURIDE |
Adrenergic alpha1A |
100% |
.023uM |
.009188uM |
View
|
dopamine receptor D3 |
LISURIDE |
Dopamine D3 |
100% |
.000173uM |
.000059uM |
View
|
5-hydroxytryptamine receptor 6 |
LISURIDE |
Serotonin 5-HT6 |
100% |
.012uM |
.005514uM |
View
|
sodium channel, voltage-gated, type I, alpha |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
amiloride-sensitive cation channel 5, intestinal |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
sodium channel, voltage-gated, type III, beta |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
TERFENADINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.624uM |
.607uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
TERFENADINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.624uM |
.607uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
TERFENADINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.624uM |
.607uM |
View
|
chemokine (C-C motif) receptor 5 |
TERFENADINE |
Chemokine CCR5 |
100% |
1.103uM |
.852uM |
View
|
prostaglandin-endoperoxide synthase 2 |
BROMFENAC |
Cyclooxygenase COX-2 |
100% |
.004803uM |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
BROMFENAC |
Cyclooxygenase COX-2 |
100% |
.004803uM |
NoneNone |
View
|
dopamine receptor 2 |
THIORIDAZINE |
Dopamine D2L |
100% |
.035uM |
.012uM |
View
|
dopamine receptor D3 |
FLUNARIZINE |
Dopamine D3 |
100% |
.097uM |
.033uM |
View
|
dopamine receptor D3 |
SULPIRIDE |
Dopamine D3 |
100% |
.169uM |
.057uM |
View
|
dopamine receptor D3 |
THIORIDAZINE |
Dopamine D3 |
100% |
.009892uM |
.00336uM |
View
|
dopamine receptor D3 |
CINNARIZINE |
Dopamine D3 |
100% |
.252uM |
.086uM |
View
|
dopamine receptor D3 |
DOMPERIDONE |
Dopamine D3 |
100% |
.018uM |
.006243uM |
View
|
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
TERFENADINE |
Dopamine Transporter |
100% |
.255uM |
.203uM |
View
|
nuclear receptor subfamily 3, group C, member 1 |
HYDROXYPROGESTERONE |
Glucocorticoid |
100% |
.051uM |
.023uM |
View
|
protein kinase C, iota |
PACLITAXEL |
Phorbol Ester |
19% |
NoneNone |
NoneNone |
View
|
histamine receptor H 1 |
DIMENHYDRINATE |
Histamine H1, Central |
100% |
.319uM |
.037uM |
View
|
histamine receptor H 1 |
TERFENADINE |
Histamine H1, Central |
100% |
.022uM |
.002587uM |
View
|
histamine receptor H 1 |
CYCLIZINE |
Histamine H1, Central |
100% |
.038uM |
.004443uM |
View
|
histamine receptor H 1 |
METHAPYRILENE |
Histamine H1, Central |
100% |
.016uM |
.001802uM |
View
|
histamine receptor H 1 |
DESLORATADINE |
Histamine H1, Central |
100% |
.009977uM |
.001159uM |
View
|
cysteinyl leukotriene receptor 1 |
MONTELUKAST |
Leukotriene D4 |
100% |
.002287uM |
.001143uM |
View
|
cysteinyl leukotriene receptor 1 |
MONTELUKAST |
Leukotriene D4 |
100% |
.002287uM |
.001143uM |
View
|
cholinergic receptor, muscarinic 1 |
THIORIDAZINE |
Muscarinic M1 |
100% |
.007019uM |
.00169uM |
View
|
cholinergic receptor, muscarinic 1 |
VALETHAMATE BROMIDE |
Muscarinic M1 |
100% |
.012uM |
.00278uM |
View
|
cholinergic receptor, muscarinic 2 |
VALETHAMATE BROMIDE |
Muscarinic M2 |
100% |
.055uM |
.019uM |
View
|
cholinergic receptor, muscarinic 3 |
VALETHAMATE BROMIDE |
Muscarinic M3 |
100% |
.026uM |
.005585uM |
View
|
cholinergic receptor, muscarinic 3 |
METHSCOPOLAMINE BROMIDE |
Muscarinic M3 |
100% |
.001129uM |
.000239uM |
View
|
cholinergic receptor, muscarinic 4 |
VALETHAMATE BROMIDE |
Muscarinic M4 |
100% |
.026uM |
.003669uM |
View
|
cholinergic receptor, muscarinic 4 |
METHSCOPOLAMINE BROMIDE |
Muscarinic M4 |
100% |
.000706uM |
.000098uM |
View
|
cholinergic receptor, muscarinic 5 |
CYCLIZINE |
Muscarinic M5 |
100% |
.633uM |
.455uM |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
GLYBURIDE |
Potassium Channel [KATP] |
100% |
.003804uM |
.000432uM |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
GLYBURIDE |
Potassium Channel [KATP] |
100% |
.003804uM |
.000432uM |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
GLYBURIDE |
Potassium Channel [KATP] |
100% |
.003804uM |
.000432uM |
View
|
progesterone receptor |
HYDROXYPROGESTERONE |
Progesterone |
100% |
.012uM |
.001549uM |
View
|
progesterone receptor |
HYDROXYPROGESTERONE |
Progesterone |
100% |
.012uM |
.001549uM |
View
|
mitogen activated protein kinase 1 |
IODOQUINOL |
Protein Serine/Threonine Kinase, ERK2 |
100% |
.294uM |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
IODOQUINOL |
Protein Serine/Threonine Kinase, ERK2 |
100% |
.294uM |
NoneNone |
View
|
mitogen activated protein kinase 14 |
IODOQUINOL |
Protein Serine/Threonine Kinase, p38alpha |
100% |
.364uM |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
IODOQUINOL |
Protein Serine/Threonine Kinase, p38alpha |
100% |
.364uM |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
CHROMIUM(III) CHLORIDE |
Protein Tyrosine Kinase, Fyn |
100% |
1.75uM |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
IODOQUINOL |
Protein Tyrosine Kinase, Fyn |
100% |
1.571uM |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
DESLORATADINE |
Serotonin 5-HT2A |
100% |
.033uM |
.00945uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
TERFENADINE |
Serotonin 5-HT2B |
100% |
.048uM |
.03uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
THIORIDAZINE |
Serotonin 5-HT2C |
100% |
.044uM |
.023uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
DESLORATADINE |
Serotonin 5-HT2C |
100% |
.03uM |
.016uM |
View
|
sodium channel, voltage-gated, type IV, beta |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel associated protein 1 |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel associated protein 2 |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, voltage-gated, type III, beta |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, voltage-gated, type I, alpha |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
adrenergic receptor, alpha 2b |
CIGLITAZONE |
Adrenergic alpha2B |
100% |
13.258uM |
6.053uM |
View
|
histamine receptor H 1 |
DEXCHLORPHENIRAMINE |
Histamine H1, Central |
100% |
.006288uM |
.00073uM |
View
|
prostaglandin-endoperoxide synthase 1 |
INDOMETHACIN |
Cyclooxygenase COX-1 |
100% |
.015uM |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
INDOMETHACIN |
Cyclooxygenase COX-1 |
100% |
.015uM |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
DEXIBUPROFEN |
Cyclooxygenase COX-1 |
100% |
.105uM |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
DEXIBUPROFEN |
Cyclooxygenase COX-1 |
100% |
.105uM |
NoneNone |
View
|
opioid receptor, kappa 1 |
MICONAZOLE |
Opiate kappa |
100% |
6.594uM |
2.637uM |
View
|
sodium channel, voltage-gated, type IV, beta |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel associated protein 1 |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel associated protein 2 |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type III, beta |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type I, alpha |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
amiloride-sensitive cation channel 5, intestinal |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type III, beta |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type I, beta |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type II, beta |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, nonvoltage-gated 1 gamma |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, nonvoltage-gated 1 beta |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, nonvoltage-gated 1, gamma |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, nonvoltage-gated 1, delta |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type X, alpha |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage gated, type VIII, alpha |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type IV, beta |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type IV, alpha |
MICONAZOLE |
Sodium Channel, Site 2 |
100% |
3.065uM |
2.748uM |
View
|
sodium channel, voltage-gated, type III, alpha |
DANAZOL |
Sodium Channel, Site 2 |
100% |
2.978uM |
2.67uM |
View
|
sodium channel, voltage-gated, type II, beta |
DANAZOL |
Sodium Channel, Site 2 |
100% |
2.978uM |
2.67uM |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
DANAZOL |
Sodium Channel, Site 2 |
100% |
2.978uM |
2.67uM |
View
|
sodium channel, voltage-gated, type I, beta |
DANAZOL |
Sodium Channel, Site 2 |
100% |
2.978uM |
2.67uM |
View
|
sodium channel, voltage-gated, type I, alpha |
DANAZOL |
Sodium Channel, Site 2 |
100% |
2.978uM |
2.67uM |
View
|
arachidonate 15-lipoxygenase, second type |
DIETHYLSTILBESTROL |
Lipoxygenase 15-LO |
100% |
2.963uM |
NoneNone |
View
|
arachidonate 15-lipoxygenase |
DIETHYLSTILBESTROL |
Lipoxygenase 15-LO |
100% |
2.963uM |
NoneNone |
View
|
arachidonate 15-lipoxygenase |
DIETHYLSTILBESTROL |
Lipoxygenase 15-LO |
100% |
2.963uM |
NoneNone |
View
|
aldo-keto reductase family 1, member B4 (aldose reductase) |
TYRPHOSTIN A23 |
Aldose Reductase |
100% |
.202uM |
NoneNone |
View
|
aldo-keto reductase family 1, member B1 (aldose reductase) |
TYRPHOSTIN A23 |
Aldose Reductase |
100% |
.202uM |
NoneNone |
View
|
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
TYRPHOSTIN A23 |
Aldose Reductase |
100% |
.202uM |
NoneNone |
View
|
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
TYRPHOSTIN A23 |
Aldose Reductase |
100% |
.202uM |
NoneNone |
View
|
androgen receptor |
DANAZOL |
Testosterone |
100% |
.012uM |
.00799uM |
View
|
Cytochrom P450-1A2 monooxygenase |
SULCONAZOLE |
CYP450-1A2 Inhibition |
100% |
.6uM |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
SULCONAZOLE |
CYP450-2C19 Inhibition |
100% |
.016uM |
NoneNone |
View
|
progesterone receptor |
DANAZOL |
Progesterone |
100% |
.259uM |
.034uM |
View
|
progesterone receptor |
DANAZOL |
Progesterone |
100% |
.259uM |
.034uM |
View
|
adrenergic receptor, alpha 2b |
SULCONAZOLE |
Adrenergic alpha2B |
100% |
3.584uM |
1.636uM |
View
|
dopamine receptor D3 |
AURANOFIN |
Dopamine D3 |
100% |
.659uM |
.224uM |
View
|
tachykinin receptor 2 |
SULCONAZOLE |
Tachykinin NK2 |
100% |
4.958uM |
1.653uM |
View
|
sodium channel, voltage-gated, type IV, beta |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel associated protein 1 |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel associated protein 2 |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type III, beta |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type I, alpha |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
amiloride-sensitive cation channel 5, intestinal |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type III, beta |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type I, beta |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type II, beta |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, nonvoltage-gated 1 gamma |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, nonvoltage-gated 1 beta |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, nonvoltage-gated 1, gamma |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, nonvoltage-gated 1, delta |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type X, alpha |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage gated, type VIII, alpha |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type IV, beta |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type IV, alpha |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type III, alpha |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type II, beta |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type I, beta |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
sodium channel, voltage-gated, type I, alpha |
SULCONAZOLE |
Sodium Channel, Site 2 |
100% |
1.988uM |
1.814uM |
View
|
dopamine receptor D3 |
SULCONAZOLE |
Dopamine D3 |
100% |
3.104uM |
1.054uM |
View
|
cholinergic receptor, muscarinic 3 |
SULCONAZOLE |
Muscarinic M3 |
100% |
3.404uM |
.721uM |
View
|
nuclear receptor subfamily 3, group C, member 1 |
PREDNISOLONE |
Glucocorticoid |
100% |
.016uM |
.007397uM |
View
|
nuclear receptor subfamily 3, group C, member 1 |
BUDESONIDE |
Glucocorticoid |
100% |
.004475uM |
.002034uM |
View
|
carbonic anhydrase 5a, mitochondrial |
ACETAZOLAMIDE |
Carbonic Anhydrase |
100% |
.101uM |
NoneNone |
View
|
carbonic anhydrase 3 |
ACETAZOLAMIDE |
Carbonic Anhydrase |
100% |
.101uM |
NoneNone |
View
|
carbonic anhydrase 2 |
ACETAZOLAMIDE |
Carbonic Anhydrase |
100% |
.101uM |
NoneNone |
View
|